TY - GEN
T1 - All-dielectric Metasurfaces Enabling Imaging-based Real-time Biosensing
AU - Jahani, Yasaman
AU - Arvelo, Eduardo R.
AU - Yesilkoy, Filiz
AU - Koshelev, Kirill
AU - Cianciaruso, Chiara
AU - De Palma, Michele
AU - Kivshar, Yuri
AU - Altug, Hatice
N1 - Publisher Copyright:
© 2021 IEEE.
PY - 2021/6
Y1 - 2021/6
N2 - Nanophotonics has come to light for detecting biomolecules and pathogens in an expeditious, highly- sensitive, label-free, and multiplexed manner. This is notably essential in disease prevention, early detection, drug development, and treatment monitoring. Refractometric biosensors rely on optical resonators exhibiting a resonance, which undergoes a spectral shift when the local refractive index changes due to bioanalyte bindings. Current spectroscopic approaches to monitor these wavelength shifts are using bulky, expensive, and sophisticated instrumentations, which limit their widespread exploitation, especially in point-of-care settings. Alternatively, tracking intensity changes over a narrow spectral window can substitute for collecting spectrally resolved information over a broad bandwidth to monitor the resonance shifts. Intensity-based platforms can be as simple as on-chip light sources and imaging detectors, offering miniaturization, lower cost, and portability to nanophotonic biosensors. However, intensity-interrogation is prone to noise factors, making them unreliable. Therefore, there is a need for novel approaches for robust and accurate miniaturized nanobiosensors that can also have an easier path forward to commercialization.
AB - Nanophotonics has come to light for detecting biomolecules and pathogens in an expeditious, highly- sensitive, label-free, and multiplexed manner. This is notably essential in disease prevention, early detection, drug development, and treatment monitoring. Refractometric biosensors rely on optical resonators exhibiting a resonance, which undergoes a spectral shift when the local refractive index changes due to bioanalyte bindings. Current spectroscopic approaches to monitor these wavelength shifts are using bulky, expensive, and sophisticated instrumentations, which limit their widespread exploitation, especially in point-of-care settings. Alternatively, tracking intensity changes over a narrow spectral window can substitute for collecting spectrally resolved information over a broad bandwidth to monitor the resonance shifts. Intensity-based platforms can be as simple as on-chip light sources and imaging detectors, offering miniaturization, lower cost, and portability to nanophotonic biosensors. However, intensity-interrogation is prone to noise factors, making them unreliable. Therefore, there is a need for novel approaches for robust and accurate miniaturized nanobiosensors that can also have an easier path forward to commercialization.
UR - http://www.scopus.com/inward/record.url?scp=85117586243&partnerID=8YFLogxK
U2 - 10.1109/CLEO/Europe-EQEC52157.2021.9541685
DO - 10.1109/CLEO/Europe-EQEC52157.2021.9541685
M3 - Conference Paper
AN - SCOPUS:85117586243
T3 - 2021 Conference on Lasers and Electro-Optics Europe and European Quantum Electronics Conference, CLEO/Europe-EQEC 2021
BT - 2021 Conference on Lasers and Electro-Optics Europe and European Quantum Electronics Conference, CLEO/Europe-EQEC 2021
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 2021 Conference on Lasers and Electro-Optics Europe and European Quantum Electronics Conference, CLEO/Europe-EQEC 2021
Y2 - 21 June 2021 through 25 June 2021
ER -